There was no difference in second primary cancer risk among older adult male patients treated with intensity-modulated radiotherapy (IMRT) vs 3-dimensional conformal radiation therapy for prostate ...
In a randomized trial of men with intermediate-risk prostate cancer, stereotactic body radiotherapy (SBRT) improved bowel-related quality of life vs moderately hypofractionated intensity-modulated ...
Vancouver, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The global Intensity Modulated Radiotherapy (IMRT) market size was USD 2.21 Billion in 2022 and is expected to register a steady revenue CAGR of 5.4% ...
Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the ...
Proton therapy reduces radiation to nontargeted tissues, but for men with localized prostate cancer that may not translate to better outcomes, according to early results from the large prospective ...
Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Intensity-modulated Radiotherapy Market, Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The global ...
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma Clinical trials frequently include multiple ...
People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy—proton beam therapy or intensity modulated radiation therapy (IMRT)—achieved ...
People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy - proton beam therapy or intensity modulated radiation therapy (IMRT) - ...
Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the ...
LOS ANGELES, Oct. 28 – Results from a University of Pittsburgh study demonstrate that intensity-modulated radiation therapy (IMRT) for head and neck cancer can be uniformly delivered in a large health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results